Genenta Science S.p.A. stock surged after ANEMOCYTE partnership. Discover temferon's cancer trial updates and what’s next.
Ancient DNA from Napoleon’s soldiers reveals enteric and relapsing fevers - not typhus - as key killers during the army’s ...
Investing.com -- 4basebio PLC (AIM:4BB) stock surged 6.9% on Monday after announcing that a global Tier 1 pharmaceutical partner has begun dosing patients in Phase I/II clinical trials using the ...
From CRISPR to gene banking, synthetic biology has big implications for wildlife evolution and conservation, but ethical ...
Human remains found in an abandoned home in Georgia nearly four years ago have been identified by Othram, a forensic laboratory, as Christopher Lamont Williams ...
Pharmaceutical Technology on MSN
Guardant and Zephyr AI pair up to advance cancer biomarker development
Guardant Health and Zephyr AI have partnered to advance the discovery of novel cancer biomarkers, as more precise tumour ...
From the telecoms side, Vodafone’s Darren Ennis called for a framework that is “future-proofed” and “fair”, stressing the ...
When it comes to treating disease, one promising avenue is addressing the presence of senescent cells. These cells—also known ...
SINGAPORE, Oct. 27, 2025 /PRNewswire/ — Raffles Medical Group (the Group) and Gene Solutions have signed a Memorandum of ...
As enterprise AI company Uniphore raises $260 million from AI and data majors Nvidia, AMD, Snowflake, Databricks and other ...
The collaboration will progress under the combined company, NewCelX, upon completion of the anticipated merger ZURICH and NESS ZIONA, Israel, Oct. 27, 2025 /PRNewswire/ -- NLS Pharmaceutics ...
7hon MSN
New breakthrough treatment destroys up to 90% of skin and colon cancer cells in just 30 minutes
A new groundbreaking light therapy could kill cancer cells in just 30 minutes, scientists have discovered. In the new method, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results